COLGATE PALMOLIVE CO·4

Feb 12, 4:08 PM ET

Hazlin John 4

4 · COLGATE PALMOLIVE CO · Filed Feb 12, 2026

Research Summary

AI-generated summary of this filing

Updated

Colgate-Palmolive (CL) CGO John Hazlin Exercises Options, Sells Shares

What Happened

  • John Hazlin, Chief Growth Officer of Colgate-Palmolive (CL), exercised stock options and immediately sold the resulting shares on Feb 10, 2026. He exercised 20,989 options at $76.41 per share (exercise value ≈ $1,603,769) and sold the 20,989 shares in the open market at a weighted average price of $94.25 per share (gross proceeds ≈ $1,978,211). The shares were sold the same day as the exercise, indicating a cashless exercise/sale.

Key Details

  • Transaction dates: 2026-02-10 (exercise and sale); filing date: 2026-02-12 (appears timely).
  • Exercise: 20,989 options @ $76.41 (total exercise amount ≈ $1,603,769). (F1)
  • Sale: 20,989 shares @ weighted avg. $94.25 (gross proceeds ≈ $1,978,211). Prices ranged $94.19–$94.30. (F3)
  • Related entries: the option/derivative was converted/exercised and those shares were disposed via sale; a portion of sale proceeds was delivered to the issuer to cover the exercise price and tax withholding. (F2)
  • Shares owned after transaction: not disclosed in the provided excerpt.
  • Vesting detail: the option became exercisable in one-third increments beginning on the first anniversary of the Sept 10, 2020 grant date. (F4)

Context

  • This was a common cashless exercise: options were exercised and the resulting shares were sold the same day, with proceeds used to pay the exercise price and tax withholding. Such transactions are routine for employees exercising vested compensation and do not, by themselves, indicate a change in insider confidence beyond exercising vested awards.
  • Transaction codes: M = option exercise/conversion; S = sale.

Insider Transaction Report

Form 4
Period: 2026-02-10
Hazlin John
Chief Growth Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-10$76.41/sh+20,989$1,603,76938,634 total
  • Sale

    Common Stock

    [F2][F3]
    2026-02-10$94.25/sh20,989$1,978,21117,645 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F4]
    2026-02-1020,9890 total
    Exercise: $76.41Exp: 2028-09-10Common Stock (20,989 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    5,452
Footnotes (4)
  • [F1]Exercise of stock options awarded under the issuer's incentive compensation plan.
  • [F2]Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
  • [F3]Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.19 to $94.30 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact|2026-02-12

Documents

1 file
  • 4
    doc4.xmlPrimary